139 related articles for article (PubMed ID: 6196821)
1. The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.
Balldin G; Borgström A; Genell S; Ohlsson K
Res Exp Med (Berl); 1983; 183(3):203-13. PubMed ID: 6196821
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
Berling R; Borgström A; Ohlsson K
Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
[TBL] [Abstract][Full Text] [Related]
3. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
Lasson A; Ohlsson K
Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal lavage efficiently eliminates protease-alpha-2-macroglobulin complexes and components of the contact system from the peritoneal cavity in patients with severe acute pancreatitis.
Aasen AO; Ruud TE; Roeise O; Bouma BN; Stadaas JO
Eur Surg Res; 1989; 21(1):1-10. PubMed ID: 2469582
[TBL] [Abstract][Full Text] [Related]
5. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis.
Balldin G; Eddeland A; Ohlsson K
Scand J Gastroenterol; 1981; 16(5):603-9. PubMed ID: 6172839
[TBL] [Abstract][Full Text] [Related]
6. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
Lasson A; Ohlsson K
Biochim Biophys Acta; 1982 Dec; 709(2):227-33. PubMed ID: 6185150
[TBL] [Abstract][Full Text] [Related]
7. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
Lasson A; Dittmann B; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
[TBL] [Abstract][Full Text] [Related]
8. Effective intraperitoneal antiprotease therapy for taurocholate-induced pancreatitis in rats.
Wilson C; Imrie CW
Br J Surg; 1990 Nov; 77(11):1252-5. PubMed ID: 1701328
[TBL] [Abstract][Full Text] [Related]
9. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment.
Lasson A
Scand J Gastroenterol Suppl; 1984; 99():1-57. PubMed ID: 6205440
[TBL] [Abstract][Full Text] [Related]
10. Influence of the human pancreatic secretory trypsin inhibitor on trypsin-induced C3 and kininogen cleavage: an in vitro study.
Ohlsson K
Scand J Gastroenterol Suppl; 1986; 126():18-20. PubMed ID: 2436281
[TBL] [Abstract][Full Text] [Related]
11. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin.
Bläckberg M; Berling R; Ohlsson K
Pancreas; 1999 Nov; 19(4):325-34. PubMed ID: 10547191
[TBL] [Abstract][Full Text] [Related]
12. Continuous peritoneal dialysis in acute experimental pancreatitis in dogs. Effect of aprotinin in the dialysate medium.
Bassi C; Briani G; Vesentini S; Orcalli F; Falconi M; Vantini I; Cavallini G; Maffezzoli G; Pederzoli P
Int J Pancreatol; 1989 Jul; 5(1):69-75. PubMed ID: 2473149
[TBL] [Abstract][Full Text] [Related]
13. The effect of peritoneal dialysis with and without aprotinin on acute experimental pancreatitis in rats.
Tilquin BM; O'Connor TC; Hancotte-La Haye CM; Gonze DM; Reynaert MS; De Muylder CG; Kestens PJ
Int Surg; 1990; 75(3):174-8. PubMed ID: 1700770
[TBL] [Abstract][Full Text] [Related]
14. Protease-antiprotease interactions and the rationale for therapeutic protease inhibitors.
Schmid S; Uhl W; Büchler MW
Scand J Gastroenterol Suppl; 1996; 219():47-50. PubMed ID: 8865472
[TBL] [Abstract][Full Text] [Related]
15. Trypsin-induced release of bradykinin and of C3 fragments in man: clinical and experimental studies on the protective role of alpha 2-macroglobulin and aprotinin.
Ohlsson F; Balldin G; Lasson A
Adv Exp Med Biol; 1983; 156 (Pt B)():1083-90. PubMed ID: 6190382
[No Abstract] [Full Text] [Related]
16. Kinin activation and protease inhibitors in acute pancreatitis in man.
Lasson A; Ohlsson K
Adv Exp Med Biol; 1986; 198 Pt B():423-32. PubMed ID: 2433917
[TBL] [Abstract][Full Text] [Related]
17. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis.
Mayer AD; McMahon MJ; Corfield AP; Cooper MJ; Williamson RC; Dickson AP; Shearer MG; Imrie CW
N Engl J Med; 1985 Feb; 312(7):399-404. PubMed ID: 2578610
[TBL] [Abstract][Full Text] [Related]
18. Human cationic, pancreatic elastase in acute pancreatitis.
Håkansson HO; Borgström A; Ohlsson K
Scand J Clin Lab Invest; 1993 Feb; 53(1):17-24. PubMed ID: 7680823
[TBL] [Abstract][Full Text] [Related]
19. Correlation among complement activation, protease inhibitors, and clinical course in acute pancreatitis in man.
Lasson A; Laurell AB; Ohlsson K
Scand J Gastroenterol; 1985 Apr; 20(3):335-45. PubMed ID: 2408321
[TBL] [Abstract][Full Text] [Related]
20. On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
Balldin G; Borgström A; Marks WH; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):751-6. PubMed ID: 6207093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
